
Caplyta (Lumateperone) Overview
Key takeaways
Caplyta (lumateperone) is a prescription oral capsule used to treat certain mental health conditions, including schizophrenia. Experts aren't sure exactly how it works, but they believe it affects two specific brain chemicals to treat certain mental health conditions.
You'll usually take Caplyta by mouth once per day. While it should start working soon after you take your first dose, it may take time to notice a difference in your symptoms.
Caplyta may cause some side effects. Mild side effects include nausea, weight gain, and headache, and these may go away after a few weeks. Serious side effects include seizures, low blood pressure, and high cholesterol.
Caplyta basics
Caplyta is used in adults to treat:
schizophrenia
depression related to bipolar I disorder or bipolar II disorder
Caplyta contains the active ingredient lumateperone. (An active ingredient is what makes a drug work.) It belongs to a group of drugs called atypical antipsychotics.
Caplyta is a brand-name prescription medication. A generic version of the drug isn't currently available.
Caplyta uses
Caplyta is used in adults to treat:
schizophrenia
depression related to bipolar I disorder or bipolar II disorder
Caplyta is not used to treat these conditions in children.
Schizophrenia causes problems with perception. It's possible for people with schizophrenia to have delusions (believing in something that's false) or hallucinations (seeing, sensing, or hearing things that aren't there).
Bipolar disorder causes extreme changes in mood, such as feeling euphoric or manic, energetic, or depressed. Two common kinds of bipolar disorder are bipolar I disorder and bipolar II disorder. With the first kind, you have a manic episode with or without a depressive episode. With the second, you experience depressive episodes and hypomanic episodes (which are less severe than manic episodes).
Caplyta is used to treat depression associated with bipolar I disorder or bipolar II disorder. (This drug isn't used to treat mania or hypomania.) For this purpose, it can be used alone or with lithium (Lithobid) or valproate.
Although the causes of schizophrenia and bipolar disorder aren't known, these conditions may occur due to an imbalance of chemicals in the brain. It's thought that Caplyta affects two different hormones in the brain, serotonin and dopamine, which may help to decrease the symptoms of these conditions.
What are Caplyta's side effects?
Like most drugs, Caplyta may cause mild or serious side effects. The lists that follow describe some of the more common side effects that Caplyta may cause. These lists don't include all possible side effects.
Keep in mind that side effects of a drug can depend on:
your age
other health conditions you have
other medications you take
Your doctor or pharmacist can tell you more about the potential side effects of Caplyta. They can also suggest ways to help reduce side effects.
Mild side effects
Here's a short list of some of the mild side effects that Caplyta can cause. To learn about other mild side effects, talk with your doctor or pharmacist, or read Caplyta's prescribing information.
Mild side effects of Caplyta that have been reported include:
nausea
dry mouth
dizziness
sleepiness or sedation (feeling drowsy or less alert)
weight gain
headache
For more information about some of these side effects, see the 'Side effect focus' section.
Mild side effects of many drugs may go away within a few days to a couple of weeks. But if they become bothersome, talk with your doctor or pharmacist.
Serious side effects
Serious side effects from Caplyta can occur, but they aren't common. If you have serious side effects from Caplyta, call your doctor right away. But if you think you're having a medical emergency, immediately call 911 or your local emergency number.
Serious side effects of Caplyta or antipsychotic drugs such as Caplyta that have been reported include:
neuroleptic malignant syndrome, a rare but serious condition that can occur in people taking antipsychotic medications
high blood sugar, which can lead to diabetes
high cholesterol or high triglycerides
difficulty swallowing
seizures
problems maintaining body temperature
low levels of white blood cells
low blood pressure when standing up that can lead to passing out
tardive dyskinesia, which causes unusual and unintended muscle movements
boxed warnings:
risk of suicidal thoughts or behaviors
risk of death in older adults with psychosis related to dementia (problems with thinking, memory, and communication)
allergic reaction
For more information about Caplyta's boxed warnings and allergic reaction, see the next section.
Side effect focus
Learn more about some of the side effects Caplyta may cause.
Boxed warning: Risk of suicidal thoughts and behaviors in certain people
Caplyta has a boxed warning for the risk of suicidal thoughts and behaviors in certain people. A boxed warning is the most serious warning from the Food and Drug Administration (FDA).
Antidepressant medications may increase the risk of suicidal thoughts or behaviors in children and young adults. This includes Caplyta, which is prescribed to treat depression related to bipolar disorder. Since Caplyta is only approved for use in adults, this risk may affect adults ages 18 to 24 years who take this drug.
What might help
Before you start taking Caplyta, talk with your doctor about your mental health history. And tell your family and friends about this warning for Caplyta. Your risk of suicidal thoughts or behaviors can be worse at the start of treatment and when your doctor changes your drug dosage.
If you notice any symptoms of worsening depression, changes in mood, or suicidal thoughts or behaviors, contact a doctor right away for treatment. Examples of symptoms to watch for include:
feeling alone
not enjoying activities that used to make you happy
thoughts of harming yourself
anxiety
changes in your sleep patterns
If you notice worsening of your mood or that you're having suicidal thoughts or behaviors, your doctor may recommend that you stop taking Caplyta.
Help is out there
If you or someone you know is in crisis and considering suicide or self-harm, please seek support:
Call or text the 988 Suicide and Crisis Lifeline at 988 or chat at 988lifeline.org. Caring counselors are available to listen and provide free and confidential support 24/7.
Text HOME to the Crisis Text Line at 741741 to connect with a volunteer crisis counselor for free and confidential support 24/7.
Not in the United States? Find a helpline in your country with Befrienders Worldwide.
Call 911 or your local emergency services number if you feel safe to do so.
If you're calling on behalf of someone else, stay with them until help arrives. You may remove weapons or substances that can cause harm if you can do so safely.
If you're not in the same household, stay on the phone with them until help arrives.
Boxed warning: Risk of death in older adults with psychosis related to dementia
Caplyta has a boxed warning for the risk of death in older adults with psychosis related to dementia. A boxed warning is the most serious warning from the Food and Drug Administration (FDA).
Antipsychotic drugs such as Caplyta may increase the risk of death in adults ages 65 years or older with dementia -related psychosis. Dementia is a condition that affects memory. Psychosis involves losing touch with reality.
Older adults with dementia-related psychosis who take Caplyta may also have an increased risk of stroke.
What might help
Due to the risk of death, it's not likely that a doctor would prescribe Caplyta to an older adult with dementia-related psychosis. Before starting Caplyta treatment, tell your doctor about any history of dementia-related psychosis that you have. In this case, your doctor may recommend a different treatment option for you.
Weight gain
Antipsychotic medications such as Caplyta may cause weight gain. This is because the drug can cause changes in a person's metabolism.
Although weight gain wasn't one of the most common side effects of Caplyta, it may still occur in people taking it.
What might help
Before you start taking Caplyta, your doctor will check your weight and continue to monitor it throughout treatment. If you experience weight gain while you're taking Caplyta, talk with your doctor. They may be able to recommend changes in your diet or exercise routine that can help you with weight management.
Headache
You may have headaches from taking Caplyta, although this isn't one of the most common side effects of the drug. In studies, only people taking this medication to treat depression related to bipolar disorder reported headaches. This side effect wasn't reported in people taking it for schizophrenia.
What might help
If you have headaches during Caplyta treatment, talk with your doctor. They may recommend ways to help treat this side effect. For example, your doctor may suggest taking an over-the-counter pain medication, such as acetaminophen (Tylenol), to ease headache pain.
Allergic reaction
Some people may have an allergic reaction to Caplyta.
Symptoms of a mild allergic reaction can include:
skin rash
itchiness
flushing (temporary warmth, redness, or deepening of skin color)
A more severe allergic reaction is rare but possible. Symptoms of a severe allergic reaction can include swelling under your skin, usually in your eyelids, lips, hands, or feet. They can also include swelling of your tongue, mouth, or throat, which can cause difficulty breathing.
Call your doctor right away if you have an allergic reaction to Caplyta. But if you think you're having a medical emergency, call 911 or your local emergency number.
What are some frequently asked questions about Caplyta?
Find answers to some commonly asked questions about Caplyta.
How does Caplyta work (what is its mechanism of action)?
Caplyta contains the active ingredient lumateperone, which belongs to the atypical antipsychotic group of drugs.
Caplyta is used to treat schizophrenia and depression related to bipolar disorder.
It's not entirely clear how Caplyta works to treat these conditions. Researchers believe the drug affects certain brain chemicals, which decreases symptoms of schizophrenia and depression related to bipolar disorder.
» For more about Caplyta's mechanism of action, see this overview on how Caplyta works.
What should I know about alternatives to Caplyta, such as Vraylar, clozapine, Abilify, Latuda, and Seroquel?
Many different treatment options are available for schizophrenia and depression related to bipolar disorder. Before starting any treatment options, you should discuss with your doctor what may be the best medication for you.
The following list includes a few examples of drugs used to treat schizophrenia and depression related to certain kinds of bipolar disorder:
cariprazine (Vraylar)
aripiprazole (Abilify)
lurasidone (Latuda)
quetiapine (Seroquel)
Clozapine (Clozaril) can be used to treat schizophrenia.
Some of these medications can also be prescribed to treat other conditions.
These medications may have different side effects and different dosing schedules. Some will likely require different lab tests for monitoring certain side effects.
Before you start treatment for schizophrenia or depression related to bipolar disorder, talk with your doctor. They can work with you to determine which medication may be best for your condition.
What's the half-life of Caplyta?
The half-life of Caplyta is about 18 hours. A half-life is the amount of time it takes for the body to rid itself of half of a dose of medication. So taking your dose of Caplyta every day helps to keep a consistent amount of the drug in your body.
Caplyta's price and coupons
As with other prescription drugs, the cost of Caplyta can vary depending on many factors. These factors include what your insurance plan covers and which pharmacy you use.
If you have questions about how to pay for your prescription, talk with your doctor or pharmacist. You can also visit the Caplyta manufacturer's website to see whether it has support options that you qualify for.
And check out these tips for saving money on prescriptions.
Savings for Caplyta
You can visit Optum Perks for price estimates of Caplyta. These estimates are based on the use of Optum Perks coupons. Note: Optum Perks coupons cannot be used with insurance copays or benefits.
What is Caplyta's dosage?
Your doctor will recommend the dosage of Caplyta that's right for you. Here you'll find commonly used dosages, but always take the dosage your doctor prescribes.
Form and strengths
Caplyta comes as a capsule that you swallow. It's available in three strengths:
42 milligrams (mg)
21 mg
10.5 mg
Recommended dosage
The recommended dosage of Caplyta is 42 mg once per day, which you'll take by mouth. The dosage is the same for schizophrenia and depression related to bipolar I disorder or bipolar II disorder, the conditions Caplyta is used to treat.
Your doctor may lower your dosage if you take certain medications or have liver problems. Before you start taking Caplyta, be sure to tell your doctor about any medications you may take and health conditions you may have.
Questions about Caplyta's dosage
Here are some answers to questions you may have about Caplyta's dosage.
What if I miss a dose of Caplyta? If you miss your dose of Caplyta, talk with your doctor or pharmacist about the best time to take your next dose. In some cases, they may recommend that you take your dose as soon as you remember. Or they may recommend that you skip the dose you missed and continue with your regular dosing schedule.
Will I need to use Caplyta long term? If Caplyta works for you, your doctor will likely recommend that you take it long term.
How long does Caplyta take to work? Caplyta begins working as soon as you take your first dose. But since the drug affects chemical levels in your brain, it may take time to notice a difference in your mood. It takes about 5 days for Caplyta to reach a consistent level in your body.
How is Caplyta taken?
Your doctor will explain how you should take Caplyta. They'll also explain how much to take and how often. Be sure to follow your doctor's instructions.
Taking Caplyta
You'll take Caplyta capsules by mouth once daily. Try to take your dose of Caplyta at about the same time each day. This helps to keep a consistent level of the medication in your body.
Accessible medication containers and labels
If it's hard for you to read the label on your prescription, tell your doctor or pharmacist. Certain pharmacies may provide medication labels that:
have large print
use braille
contain a code you can scan with a smartphone to change the text into audio
Your doctor or pharmacist may be able to recommend a pharmacy that offers these options if your current pharmacy doesn't.
Also, if you're having difficulty opening your medication bottles, let your pharmacist know. They may be able to put Caplyta in an easy-open container. Your pharmacist may also recommend tools to help make it easier to open the drug's container.
Taking Caplyta with other drugs
In some cases, your doctor may recommend that you take your dose of Caplyta together with other medications for your condition. For example, to treat depression related to bipolar disorder, your doctor may recommend that you also take either lithium (Lithobid) or valproate with Caplyta. Before you start taking Caplyta, your doctor will recommend the best treatment plan for your condition.
Questions about taking Caplyta
Here are some answers to questions you may have about taking Caplyta.
Can Caplyta be chewed, crushed, or split? No, you should not chew, crush, or split Caplyta tablets. The manufacturer of Caplyta doesn't specify whether the capsules can be opened. So it's recommended that you take your Caplyta dose as a whole capsule.
If you have difficulty swallowing your capsules, see these tips for swallowing pills. Or talk with your doctor about using a different treatment for your condition.
Should I take Caplyta with food? You can take your dose of Caplyta with or without food.
Questions for your doctor
You may have questions about Caplyta and your treatment plan. It's important to discuss all your concerns with your doctor.
Here are a few tips that might help guide your discussion:
Before your appointment, write down questions such as:
How will Caplyta affect my body, mood, or lifestyle?
Bring someone with you to your appointment if doing so will help you feel more comfortable.
If you don't understand something related to your condition or treatment, ask your doctor to explain it to you.
Remember, your doctor and other healthcare professionals are available to help you. And they want you to get the best care possible. So don't be afraid to ask questions or offer feedback on your treatment.
What should be considered before taking Caplyta?
Before you start taking Caplyta, it's important to talk with your doctor about other medications that you take. You should also tell your doctor about any medical conditions that you have. Letting your doctor know about these factors will help them determine whether Caplyta may be a safe and effective treatment option for you.
Interactions
Taking a medication with certain vaccines, foods, and other items can affect how the medication works. These effects are called interactions.
Before taking Caplyta, be sure to tell your doctor about all medications you take, including prescription and over-the-counter kinds. Also describe any vitamins, herbs, or supplements you use. Your doctor or pharmacist can tell you about any interactions Caplyta may cause with these items.
Interactions with drugs or supplements
Caplyta can interact with several kinds of drugs. These drugs include:
certain seizure medications, such as phenytoin (Dilantin) and carbamazepine (Tegretol)
certain antibiotics, such as ciprofloxacin (Cipro), erythromycin (Eryc), and clarithromycin
certain antifungal medications, such as fluconazole (Diflucan), itraconazole (Sporanox), and voriconazole (Vfend)
certain heart medications, such as diltiazem (Cardizem) and verapamil (Verelan)
certain HIV medications, such as ritonavir (Norvir), nelfinavir (Viracept), efavirenz, and etravirine (Intelence)
the antidepressant medication nefazodone
the tuberculosis medication rifampin (Rimactane)
the lung medication bosentan (Tracleer)
the narcolepsy drugs modafinil (Provigil) and armodafinil (Nuvigil)
the nausea and vomiting medication aprepitant (Emend)
This list does not contain all kinds of drugs that may interact with Caplyta. Your doctor or pharmacist can tell you more about these interactions and any others that may occur with Caplyta.
Other interactions
You should avoid consuming grapefruit or grapefruit juice while taking Caplyta. Grapefruit can reduce how your liver breaks down Caplyta, which can cause you to have more side effects.
In addition, Caplyta can also interact with the herbal supplement St. John's wort. If you're taking this supplement, talk with your doctor before starting Caplyta.
Boxed warnings
Caplyta has boxed warnings. A boxed warning is the most serious warning from the Food and Drug Administration (FDA) about drug effects that may be dangerous.
Caplyta's boxed warnings include:
Risk of suicidal thoughts or actions in certain people: Antidepressant medications may increase the risk of suicidal thoughts or behaviors in children and young adults. This includes Caplyta, which is used to treat depression related to bipolar disorder. Since Caplyta is only approved for use in adults, this risk may affect adults ages 18 to 24 years who take this drug.
For more information about these boxed warnings, see the ' What are Caplyta's side effects? ' section.
Other warnings
Before taking Caplyta, discuss your health history with your doctor. Caplyta may not be right for you if you have certain medical conditions or other factors affecting your health. Be sure to talk with your doctor if any of the following apply to you:
diabetes
an allergic reaction to Caplyta or any of its ingredients
high triglycerides or high cholesterol levels
low white blood cell levels
seizures
low or high blood pressure
liver problems
heart problems
a history or risk of stroke
difficulty regulating body temperature
Caplyta and alcohol
There are no known interactions between Caplyta and alcohol. But drinking alcohol while taking this medication may increase your risk of certain side effects. Examples include nausea, vomiting, and sleepiness.
In addition, consuming alcohol while taking Caplyta can affect your ability to drive a car. Keep in mind that you should not drive or operate machinery until you know how Caplyta affects you. This is because the drug may cause problems with motor skills, thinking, or judgment, which can impact your ability to do certain activities, including driving a car.
If you drink alcohol, talk with your doctor about how much alcohol (if any) is safe for you to drink while you're taking Caplyta.
Pregnancy and breastfeeding
It's unknown whether Caplyta is safe to take during pregnancy or while breastfeeding.
If you can become pregnant, are breastfeeding, or are using birth control, it's important to consider whether Caplyta is a safe choice for you.
You can refer to this Caplyta reproductive health article for more information. If you have additional questions, talk with your doctor.
What should be done in case of overdose?
Do not take more Caplyta than your doctor prescribes. Taking more than this can lead to serious side effects.
What to do in case you take too much Caplyta
Call your doctor if you think you've taken too much Caplyta. You can also call 800-222-1222 to reach America's Poison Centers or use its online resource. But if you have severe symptoms, immediately call 911 or your local emergency number. Or go to the nearest emergency room.
Ask a pharmacist
A:
It's unlikely that your doctor would change your dose of Caplyta if it isn't working. The manufacturer of Caplyta doesn't recommend any changes to the drug's dosage after a person starts taking it.
One study of Caplyta for treating schizophrenia found that a dose of 42 mg resulted in significantly decreased symptoms compared with a lower dose. Another found that a higher dose of the drug didn't result in increased benefits for users.
Similarly, in studies of Caplyta for treating bipolar disorder -related depression, Caplyta 42 mg once per day showed a significant decrease in symptoms.
If you feel like Caplyta isn't working for you, contact your doctor. They may be able to recommend adding another drug to your treatment or changing to another treatment for your condition.
The Healthline Pharmacist Team Answers represent the opinions of our medical experts. All content is strictly informational and should not be considered medical advice.
Disclaimer: Healthline has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Health Line
25 minutes ago
- Health Line
Ask the Expert: Should I have Biomarker Testing – and Would it Help?
Biomarker testing in colorectal cancer can help assess inherited risk and identify characteristics that may influence the disease's growth, spread, and response to treatment. Colorectal cancer (CRC) starts in the colon or rectum of the large intestine. Your doctor may refer to it as 'colon cancer' or 'rectal cancer,' depending on where the cancer develops first, but both of these diagnoses are included under the banner of CRC. CRC is treatable, and biomarker testing is a part of precision medicine in your comprehensive treatment plan. Biomarker testing in CRC can help detect cancer in its earliest, most treatable stages. It can also provide important details about cancer after a diagnosis that influence treatment and outcomes. Dr. Smitha Krishnamurthi, a gastrointestinal oncology specialist with the Cleveland Clinic, talks with Healthline about biomarker testing and who it's recommended for. What is biomarker testing? Biomarker testing refers to testing of the colorectal cancer to find out if there are certain changes in the cancer's genes and proteins that could impact prognosis [outlook] and treatment. What are the most common biomarkers, and what do they show? Biomarkers in CRC measure a variety of different biological processes and states. Each biomarker provides important details about the cancer's growth, spread, or treatment response. DNA mismatch repair Hospital pathology labs now commonly test all initial biopsies or surgical specimens of colorectal cancer for the presence of DNA mismatch repair proteins. This is done via immunohistochemistry (IHC) staining of the slides to look for [the] expression of four mismatch repair proteins: MLH1, PMS2, MSH2, and MSH6. If one or two of these proteins are missing, then the cancer has deficient DNA mismatch repair. Microsatellite instability (MSI) This is a polymerase chain reaction (PCR) or next-generation sequencing (NGS) test [that looks] for abnormalities in microsatellite regions of the cancer DNA. The test can be done on a tumor specimen or blood (liquid biopsy). Microsatellites are short, repeated sequences of DNA. If the cancer has [atypical] DNA mismatch repair, errors will appear in microsatellite regions of DNA in the form of missing bases or extra bases added to the DNA sequence. RAS gene mutations (mutations in KRAS and NRAS genes) This testing can be performed by PCR or NGS testing of the tumor or NGS testing of blood (liquid biopsy). RAS is a very important oncogene, meaning that it is a gene that, when mutated, drives cancer cell proliferation and survival. Mutations in RAS genes are found in up to 50% of colorectal cancers. BRAF V600E gene mutation This testing can be performed by PCR or NGS testing of the tumor or NGS testing of blood (liquid biopsy). The BRAF V600E protein can also be detected by IHC. BRAF is another oncogene, so when it is mutated, it leads to cancer cell proliferation and survival. BRAF V600E mutations occur in about 8% to 10% of colorectal cancers and are more common in right-sided cancers. HER2 protein overexpression by IHC or gene amplification by NGS HER2 is another oncogene — gene amplification leads to [the] overexpression of the HER2 protein. Overexpression of HER2 leads to increased signaling via the epidermal growth factor receptor pathway, leading to cancer cell proliferation and survival. PIK3CA PIK3CA is another oncogene. Mutations in PIK3CA and a related gene, PIK3R1, lead to cancer cell proliferation and survival. Mutations in PIK3CA and PIK3R1 are typically found via NGS. PTEN PTEN is a tumor suppressor gene, [which typically] suppresses cancer growth. When the PTEN gene is mutated, the protein is not expressed, and that leads to [the] proliferation of cancer. PTEN gene mutations are typically found via NGS. Who should have biomarker testing done? All patients with colorectal cancer should have testing of their cancer for DNA mismatch repair (or microsatellite instability) soon after diagnosis. This is important for patients with cancers of all stages. Patients with early stage colorectal cancer should have testing of their cancers for mutations in PIK3CA, PTEN, and PIK3R1 by the time they finish adjuvant treatment or after surgery if [they're] not having adjuvant treatment. Patients with metastatic colorectal cancer should have next-generation sequencing of the cancer soon after diagnosis, as the results may impact the initial systemic treatment. The NGS results are also useful for identifying clinical trial eligibility. Comorbidities will not affect the results of these biomarkers, so they should not affect the timing and decision making about ordering these tests. How does biomarker testing help the treatment and outcome of a diagnosis? Biomarkers can impact your treatment choices and outcomes. They can help doctors decide which medications will be the most effective, identify inherited features in cancer, and determine if adjuvant or additional therapies would improve outcomes. Immunotherapy responsiveness It is critical to know if a cancer has deficient DNA mismatch repair (dMMR) or high microsatellite instability (MSI-H) because these cancers can respond dramatically to immunotherapy in the early stage and metastatic settings. For example, patients with rectal cancer that is dMMR or MSI-H may have a complete clinical response with immunotherapy and may be able to avoid radiation and surgery. Thus, this testing needs to be done early, before treatment starts. Identifying Lynch syndrome Another important reason for testing for dMMR or MSI-H is to identify cancers caused by Lynch syndrome. Lynch syndrome is the most common type of inherited colorectal cancer and is caused by germline mutations in the genes that code for the DNA mismatch repair proteins or in another related gene called EPCAM. Most cancers with deficient mismatch repair or MSI-H are not caused by Lynch syndrome and occur sporadically. We don't want to miss patients with Lynch syndrome, however, because they can benefit from counseling about [the] prevention of Lynch syndrome-related cancers such as uterine cancer, ovarian cancer, and gastric cancer, in addition to colorectal cancer. When a patient is diagnosed with Lynch syndrome, family members can then be tested to see if they have Lynch syndrome. Recommendations for cancer screening at early stages are made for individuals with Lynch syndrome, and early screening can be lifesaving. Identifying treatment resistance Mutations in KRAS and NRAS make cancers resistant to anti-epidermal growth factor receptor therapy. Cancers with KRAS G12C mutations can be treated with a regimen that targets this mutation (adagrasib plus cetuximab or sotorasib plus panitumumab). There are also many clinical trials now studying RAS gene inhibitors in patients with metastatic colorectal cancer that have been previously treated. Cancers with BRAF V600E tend to be aggressive and less sensitive to chemotherapy. There is a Food and Drug Administration (FDA)-approved regimen targeting BRAF V600E (encorafenib plus cetuximab) in metastatic colorectal cancer that improves survival when added to first-line FOLFOX chemotherapy. It also improves survival as a second-line treatment after chemotherapy. Greater response to targeted and adjuvant therapy Metastatic colorectal cancers that demonstrate [the] overexpression or gene amplification of HER2 can be treated with a targeted regimen of tucatinib plus trastuzumab after initial chemotherapy. Another targeted treatment available for metastatic colorectal cancers that overexpress HER2 by IHC is trastuzumab deruxtecan. Patients with early stage colorectal cancer with mutations in the PIK3CA, PIK3R1, or PTEN genes should be treated with aspirin 160 milligrams daily for 3 years after adjuvant therapy or after surgery if [they're] not having adjuvant therapy. The ALASCCA trial, presented at ASCO GI [American Society of Clinical Oncology – Gastrointestinal Cancer] in 2025, compared a placebo to aspirin in this patient population and found that aspirin significantly lowered the rate of cancer recurrence at 3 years. This is rather new data. Oncologists are starting to order NGS testing for patients with early stage cancers in order to obtain this biomarker information. What should you ask your doctor? It's always OK to ask your doctor about biomarker testing and what it means for you. Important questions to consider include: Is my cancer dMMR/MSI-H? Am I a candidate for immunotherapy? Patients with early stage colorectal cancer should ask if aspirin therapy will be recommended based on biomarker testing. Patients with metastatic colorectal cancer should ask for the results of RAS/BRAF/HER2 testing and overall NGS testing results.
Yahoo
29 minutes ago
- Yahoo
Palantir and TeleTracking Team Up to Enhance Healthcare Operations Using AI-Driven Insights
TeleTracking Technologies, a leading provider of healthcare operations platforms, has teamed up with Palantir Technologies Inc. (NASDAQ:PLTR), known for its expertise in artificial intelligence systems. The two companies have formed a strategic partnership with the goal of transforming how hospitals and health systems make operational decisions, ultimately creating long-term value for healthcare providers around the world. The collaboration will integrate TeleTracking's Operations IQ platform with Palantir Technologies Inc. (NASDAQ:PLTR)'s AI-driven tools, including Foundry and AIP. This combined solution is expected to equip hospitals with near real-time, actionable insights to improve staffing efficiency, speed up decision-making, and ensure that patient needs remain the top priority. As healthcare systems continue to face increasing demands to enhance capacity and coordination without expanding their physical footprint, this partnership represents a significant step forward. By bringing together TeleTracking's operational strengths and Palantir Technologies Inc. (NASDAQ:PLTR)'s cutting-edge technology, the two aim to usher in a new era of intelligent, scalable, and efficient healthcare delivery. Alex Karp, CEO at Palantir Technologies Inc. (NASDAQ:PLTR) made the following comment: 'This partnership with TeleTracking represents the AI revolution in healthcare we are in the midst of—where we continue to move closer to a world where all hospitals and health systems are embracing, implementing and operating with an AI-powered approach, helping to streamline operations allowing for increased focus on providing the best level of care.' Palantir Technologies Inc. (NASDAQ:PLTR) is an American publicly traded company that focuses on developing software platforms designed for analyzing large volumes of data. While we acknowledge the potential of PLTR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
New Iowa law expands cancer coverage for firefighters
A bill intended to expand cancer coverage for firefighters in Iowa is now law. Gov. Kim Reynolds signed House File 969. The bill expands the definition of cancer to include all types of cancer. Currently, only 14 cancers are currently included in coverage for firefighters, police officers and emergency responders. First responders with one of those types cancers are able to qualify for disability and death benefits. Before the passage of the bill, those with other types of cancers were not. Iowa firefighters Brian Stoaks, Mike Broderick and Malcolm Cortner all passed away from cancer. Their families and friends continued the fight until the bill passed. The bill was shot down last year. For more information, click here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.